Skip to main content
TipRanks
Go Ultimate75% OFF

Alexandria Equities (A6W) AI Stock Analysis

4 Followers
DE:A6W

Alexandria Equities

(Frankfurt:A6W)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong cash generationStrong and recurring operating cash flow, together with positive free cash flow, gives Alexandria internal funding capacity despite weak reported earnings. This supports property investment, leasing activity, debt management, and resilience through periods of lower occupancy or slower tenant demand.
Negative Factors
Deep reported lossesLarge net losses and substantial impairments indicate that reported earnings quality has deteriorated materially, even though property-level margins and cash generation remain stronger. Continued write-downs or elevated costs could weaken capital efficiency and constrain financial flexibility.

Alexandria Equities (A6W) vs. iShares MSCI Germany ETF (EWG)

-25%-20%-15%-10%-5%0%5%10%15%DE:A6W-4.50%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 7.64B
Dividend Yield
6.37%
Average Volume (3M)
433
Price to Earnings (P/E)
-5.5
Beta (1Y)
0.56
Revenue Growth
-14.43%
EPS Growth
-235.74%
Country
Germany
Employees
514
Sector
Real Estate
Sector Strength
65
Industry
REIT - Office

Alexandria Equities Business Overview & Revenue Model

Company Description

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® real estate investment trust, stands as the pioneering and most seasoned entity in the specialized domain of urban office properties. Since its inception in 1994, Alexandria has uniquely f...

Alexandria Equities Earnings Call Summary

Earnings Call Date:Oct 26, 2026(Q3-2026)|% Change Since:4.02%|Next Earnings Date:Feb 01, 2027
Earnings Call SentimentPositive

The call was predominantly positive, with strong leasing volume, significant leasing of previously vacant space, progress on dispositions and capital formation, improved occupancy, disciplined expense management, reaffirmed FFO guidance, and a strong liquidity and debt-maturity profile. These positives were tempered by a 6.7% decline in same-property NOI, muted public biotech demand, elevated free rent concessions, expected 2027 occupancy pressure, reduced realized investment gain guidance, and $638 million of real estate impairments.

Positive Updates

Strong Quarterly Leasing Volume
Third-quarter leasing totaled 1,236,000 square feet, the highest quarterly volume in the last 7 quarters. Leasing of previously vacant space reached 451,000 square feet, the second-largest quarterly amount in company history. The quarter also included a weighted average lease term of about 11 years, with 74% of leasing from existing tenants.

Negative Updates

Decline in Same-Property NOI
Third-quarter same-property net operating income declined 6.7% and declined 2.8% on a cash basis. The decline was primarily driven by lower occupancy in 2026, although the performance improved from the prior quarter's 3.9% decline and 5.8% cash-basis decline.

Company Guidance

Management expects fourth-quarter leasing of about 1.25 million square feet, year-end 2026 leverage of 5.6x to 6.2x, 2026 FFO per share diluted as adjusted of $6.40 plus or minus $0.02, G&A expenses of $134 million to $154 million, realized investment gains of $65 million at the midpoint, and average real estate basis capitalized in the fourth quarter ranging from $3.4 billion to $4.9 billion, a 40% to 60% decline from 2025. The $1.9 billion midpoint for dispositions and sales of partial interest remains in place, with $2.6 billion of completed and pending transactions potentially allowing proceeds to be deferred into 2027. For 2027, 1.4 million square feet of key lease expirations are expected to have downtime ranging from 9 to 24 months on average, with expiring rent of $101 million and tenant wind-downs estimated at $30 million to $35 million; management expects temporary pressure on occupancy in the first half of 2027, same-property performance to improve from both 2026 to 2027 and from 2027 to 2028, although '27 is still expected to be negative driven by occupancy, and average occupancy growth in 2028.

Alexandria Equities Risk Analysis

Alexandria Equities disclosed 11 risk factors in its most recent earnings report. Alexandria Equities reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Alexandria Equities Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

DE:A6W against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
BXPBXP64Neutral$11.32B19.0410.32%4.39%2.67%―
VNOVNO58Neutral$7.07B-124.360.15%2.13%1.55%-106.41%
KRCKRC56Neutral$4.23B144.160.54%5.99%-3.61%-91.01%
DEIDEI54Neutral$1.66B-81.28-1.12%7.68%1.83%-208.63%
SLGSLG52Neutral$3.73B-23.79-3.53%4.83%9.02%-342450.00%

* Real Estate Sector Average

Performance Comparison

-20%0%20%DE:A6WBXPDEIKRCSLGVNODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:A6W and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:A6WAlexandria Real Estate Equities39.36-2.23-5.36%
BXPBXP63.78-2.25-3.40%
DEIDouglas Emmett9.90-0.78-7.31%
KRCKilroy Realty36.04-1.86-4.92%
SLGSL Green Realty Corp49.006.3915.00%
VNOVornado Realty Trust34.712.347.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.